FINNENCE ▪ THE WIRE FILE
THE WIRE · № 70985
News■ Unclear/unknown
Vocca raises $20M after growing from 2,000 to 15,000 medical practitioners in a year
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 12:12 UTC
LAST UPDATE2026-10-08 12:12 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
AI phone-assistant adoption in clinics hints at healthcare AI demand, but Vocca is private.
Healthcare AI traction, but private and small
CATALYST TO WATCH
Further funding or enterprise adoption data
MAIN RISK
Private company, no ticker, unverifiable metrics
FULL DISPATCH
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Vocca announced a $20M Series A led by Norrsken VC, with participation from Heal Capital, Speedinvest and Firstminute Capital. Total funding is $25 million. Vocca's first product is an AI phone assistant that automates patient calls. A year ago,...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDAI
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Vinci Pharmaceuticals Inc. Closes More Than $8 Million Series A Financing to Advance EPIPLANT™ Drug Delivery Platform2026-10-08 12:13 UTC
Vinci Pharmaceuticals Inc. Closes More Than $8 Million Series A Financing to Advance EPIPLANT™ Drug Delivery Platform2026-10-08 12:13 UTC
→CORRELATIONshares Healthcare
Psilera Greenlit to Initiate Phase 2 of NIH Grant for Alcohol Use Disorder2026-10-08 12:15 UTC
Psilera Greenlit to Initiate Phase 2 of NIH Grant for Alcohol Use Disorder2026-10-08 12:15 UTC
→CORRELATIONshares AI
Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO2026-10-08 12:08 UTC
Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO2026-10-08 12:08 UTC
→CORRELATIONshares AI
Exclusive: Sam Altman-backed Meanwhile raises $37.5M at $350M valuation2026-10-08 12:21 UTC
Exclusive: Sam Altman-backed Meanwhile raises $37.5M at $350M valuation2026-10-08 12:21 UTC
→CORRELATIONshares Healthcare
GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution2026-10-08 12:30 UTC
GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution2026-10-08 12:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.